Latest BioSLR

Confounding bioscientists and librarians alike, volume 8 issue 4 (of 6) for 2005-2006 of the cult bimonthly Bio-Science Law Review has emerged, this being April 2007. Published by Lawtext Publishing, this lovable journal leads with the now near-obligatory review of the Gowers Review, this time being a focus on Gowers' bio-impact penned by Editorial Board member Nigel Jones (Linklaters). The other main features are
* "Levelling the Genetic Field? OECD Guidelines for the Licensing of Genetic Inventions" by Freshfields Bruckhaus Deringer pair Jonathan Bell and Andrew Skudder. This is a short-and-sweet piece on a potentially vital document that has received relatively little attention in legal journals so far (you can read the original Guidelines here - they only run to 27 pages);

* "Risk Management and Transparency in Pre-Clinical Research and Early Clinical Trials: Lessons Learnt from TGN1412" by Carla Schoonderbeek (NautaDutilh), TGN1412, left, being the near-fatal treatment developed by TeGenero for leukaemia;

* "Regulation of the Use of Genetically Modified Organisms in the EU" by Taylor Wessing's Dr Gareth Morgan, this being a high-level review that provides a useful handle with which to grip such curious concepts as self-cloning.
The IPKat has a very soft spot for this publication and hopes that it continues to flourish within its little niche.
Latest BioSLR Latest BioSLR Reviewed by Jeremy on Sunday, April 08, 2007 Rating: 5

No comments:

All comments must be moderated by a member of the IPKat team before they appear on the blog. Comments will not be allowed if the contravene the IPKat policy that readers' comments should not be obscene or defamatory; they should not consist of ad hominem attacks on members of the blog team or other comment-posters and they should make a constructive contribution to the discussion of the post on which they purport to comment.

It is also the IPKat policy that comments should not be made completely anonymously, and users should use a consistent name or pseudonym (which should not itself be defamatory or obscene, or that of another real person), either in the "identity" field, or at the beginning of the comment. Current practice is to, however, allow a limited number of comments that contravene this policy, provided that the comment has a high degree of relevance and the comment chain does not become too difficult to follow.

Learn more here:

Powered by Blogger.